Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Melatonin vs Nebulized Dexmedetomidine for Emergence Agitation in Children
NCT07345715Recruiting
- Sponsor
- Tanta University
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of melatonin and dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Tanta University. Primary endpoint: Emergence agitation. Started Jul 2025; status: recruiting.
02
Drugs
melatonindexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07345715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07345715.